Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ)
CNY 24.81
(0.36%)
CNY 24.81
(0.36%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 864.22 Million CNY | -3.65% |
| 2022 | 896.98 Million CNY | 13.05% |
| 2021 | 793.45 Million CNY | 23.41% |
| 2020 | 642.94 Million CNY | 7.75% |
| 2019 | 596.67 Million CNY | -44.48% |
| 2018 | 1.07 Billion CNY | 27.9% |
| 2017 | 840.24 Million CNY | -1.26% |
| 2016 | 850.97 Million CNY | 17.6% |
| 2015 | 723.6 Million CNY | -16.21% |
| 2014 | 863.61 Million CNY | 18.28% |
| 2013 | 730.13 Million CNY | 10.22% |
| 2012 | 662.4 Million CNY | 23.22% |
| 2011 | 537.58 Million CNY | 9.32% |
| 2010 | 491.74 Million CNY | 27.83% |
| 2009 | 384.68 Million CNY | -0.25% |
| 2008 | 385.65 Million CNY | -13.22% |
| 2007 | 444.39 Million CNY | 16.44% |
| 2006 | 381.63 Million CNY | 6.86% |
| 2005 | 357.12 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 929.2 Million CNY | 7.52% |
| 2024 Q2 | 874.27 Million CNY | -5.91% |
| 2024 Q3 | 1.02 Billion CNY | 17.21% |
| 2023 Q2 | 902.99 Million CNY | -10.18% |
| 2023 FY | 864.22 Million CNY | -3.65% |
| 2023 Q1 | 1 Billion CNY | 12.08% |
| 2023 Q4 | 864.22 Million CNY | -0.95% |
| 2023 Q3 | 872.51 Million CNY | -3.38% |
| 2022 Q4 | 896.98 Million CNY | 11.08% |
| 2022 Q1 | 955.93 Million CNY | 20.48% |
| 2022 Q2 | 800.81 Million CNY | -16.23% |
| 2022 FY | 896.98 Million CNY | 13.05% |
| 2022 Q3 | 807.52 Million CNY | 0.84% |
| 2021 FY | 793.45 Million CNY | 23.41% |
| 2021 Q3 | 681.85 Million CNY | 1.78% |
| 2021 Q2 | 669.91 Million CNY | -9.71% |
| 2021 Q1 | 741.93 Million CNY | 15.4% |
| 2021 Q4 | 793.45 Million CNY | 16.37% |
| 2020 FY | 642.94 Million CNY | 7.75% |
| 2020 Q1 | 669.52 Million CNY | 12.21% |
| 2020 Q4 | 642.94 Million CNY | 26.4% |
| 2020 Q3 | 508.66 Million CNY | -6.18% |
| 2020 Q2 | 542.19 Million CNY | -19.02% |
| 2019 Q2 | 1.05 Billion CNY | -10.16% |
| 2019 Q1 | 1.17 Billion CNY | 9.15% |
| 2019 Q4 | 596.67 Million CNY | -44.78% |
| 2019 Q3 | 1.08 Billion CNY | 2.52% |
| 2019 FY | 596.67 Million CNY | -44.48% |
| 2018 Q2 | 967.59 Million CNY | 8.82% |
| 2018 FY | 1.07 Billion CNY | 27.9% |
| 2018 Q4 | 1.07 Billion CNY | 0.29% |
| 2018 Q3 | 1.07 Billion CNY | 10.75% |
| 2018 Q1 | 889.2 Million CNY | 5.83% |
| 2017 Q2 | 865.38 Million CNY | -12.06% |
| 2017 FY | 840.24 Million CNY | -1.26% |
| 2017 Q4 | 840.24 Million CNY | -6.9% |
| 2017 Q3 | 902.48 Million CNY | 4.29% |
| 2017 Q1 | 984.11 Million CNY | 15.65% |
| 2016 FY | 850.97 Million CNY | 17.6% |
| 2016 Q2 | 775.63 Million CNY | -1.52% |
| 2016 Q4 | 850.97 Million CNY | 4.93% |
| 2016 Q3 | 810.98 Million CNY | 4.56% |
| 2016 Q1 | 787.63 Million CNY | 8.85% |
| 2015 Q3 | 823.73 Million CNY | -12.81% |
| 2015 FY | 723.6 Million CNY | -16.21% |
| 2015 Q4 | 723.6 Million CNY | -12.16% |
| 2015 Q2 | 944.78 Million CNY | -2.23% |
| 2015 Q1 | 966.3 Million CNY | 11.89% |
| 2014 Q3 | 856.52 Million CNY | 4.59% |
| 2014 Q2 | 818.96 Million CNY | 6.25% |
| 2014 FY | 863.61 Million CNY | 18.28% |
| 2014 Q1 | 770.82 Million CNY | 5.57% |
| 2014 Q4 | 863.61 Million CNY | 0.83% |
| 2013 Q4 | 730.13 Million CNY | -1.74% |
| 2013 Q3 | 743.06 Million CNY | 4.22% |
| 2013 FY | 730.13 Million CNY | 10.22% |
| 2013 Q1 | 768.49 Million CNY | 16.02% |
| 2013 Q2 | 713 Million CNY | -7.22% |
| 2012 Q2 | 615.54 Million CNY | 7.56% |
| 2012 FY | 662.4 Million CNY | 23.22% |
| 2012 Q4 | 662.4 Million CNY | -3.37% |
| 2012 Q3 | 685.52 Million CNY | 11.37% |
| 2012 Q1 | 572.27 Million CNY | 6.45% |
| 2011 Q3 | 585.02 Million CNY | 6.37% |
| 2011 Q1 | 533.37 Million CNY | 8.47% |
| 2011 Q4 | 537.58 Million CNY | -8.11% |
| 2011 FY | 537.58 Million CNY | 9.32% |
| 2011 Q2 | 549.97 Million CNY | 3.11% |
| 2010 Q4 | 491.74 Million CNY | 4.07% |
| 2010 Q1 | 469.76 Million CNY | 22.12% |
| 2010 FY | 491.74 Million CNY | 27.83% |
| 2010 Q2 | 465.65 Million CNY | -0.88% |
| 2010 Q3 | 472.51 Million CNY | 1.47% |
| 2009 Q1 | 451.17 Million CNY | 16.99% |
| 2009 FY | 384.68 Million CNY | -0.25% |
| 2009 Q3 | 488.44 Million CNY | 0.79% |
| 2009 Q4 | 384.68 Million CNY | -21.24% |
| 2009 Q2 | 484.62 Million CNY | 7.41% |
| 2008 Q4 | 385.65 Million CNY | -12.32% |
| 2008 Q2 | 459.43 Million CNY | 0.0% |
| 2008 Q3 | 439.83 Million CNY | -4.27% |
| 2008 FY | 385.65 Million CNY | -13.22% |
| 2007 FY | 444.39 Million CNY | 16.44% |
| 2007 Q4 | 444.39 Million CNY | 0.0% |
| 2006 FY | 381.63 Million CNY | 6.86% |
| 2005 FY | 357.12 Million CNY | 0.0% |